Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Luna

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Elife|January 28, 2026
Mast cells promote pathology and susceptibility in tuberculosisAnanya Gupta, Vibha Taneja, Javier Rangel-Moreno, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2021
Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19)Jesús Rivero, Maribel Merino-López, Rossana Olmedo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 16, 2022
Differential Leukocyte Expression of <i>IFITM1</i> and <i>IFITM3</i> in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19Nora E Regino-Zamarripa, Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, et al.
Frontiers in Immunology|May 31, 2021
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|March 15, 2021
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
The Journal of Infectious Diseases|March 5, 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|May 17, 2021
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, et al.
Nature Communications|November 6, 2019
Membrane protein megahertz crystallography at the European XFELChris Gisriel, Jesse Coe, Romain Letrun, et al.
Nature Communications|February 1, 2020
Author Correction: Membrane protein megahertz crystallography at the European XFELChris Gisriel, Jesse Coe, Romain Letrun, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Elife|January 28, 2026
Mast cells promote pathology and susceptibility in tuberculosisAnanya Gupta, Vibha Taneja, Javier Rangel-Moreno, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2021
Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19)Jesús Rivero, Maribel Merino-López, Rossana Olmedo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 16, 2022
Differential Leukocyte Expression of <i>IFITM1</i> and <i>IFITM3</i> in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19Nora E Regino-Zamarripa, Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, et al.
Frontiers in Immunology|May 31, 2021
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|March 15, 2021
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
The Journal of Infectious Diseases|March 5, 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|May 17, 2021
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, et al.
Nature Communications|November 6, 2019
Membrane protein megahertz crystallography at the European XFELChris Gisriel, Jesse Coe, Romain Letrun, et al.
Nature Communications|February 1, 2020
Author Correction: Membrane protein megahertz crystallography at the European XFELChris Gisriel, Jesse Coe, Romain Letrun, et al.
Pageof 2